{
  "id": "56e68967edfc094c1f000002",
  "type": "yesno",
  "question": "Is protein CXCR4 used as a prognostic marker of cancer?",
  "ideal_answer": "Yes, the chemokine C-X-C motif receptor 4 (CXCR4) has been found to be a prognostic marker in various types of cancer.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/20061818",
    "http://www.ncbi.nlm.nih.gov/pubmed/23822165",
    "http://www.ncbi.nlm.nih.gov/pubmed/23650783",
    "http://www.ncbi.nlm.nih.gov/pubmed/22473623",
    "http://www.ncbi.nlm.nih.gov/pubmed/21234386",
    "http://www.ncbi.nlm.nih.gov/pubmed/22075627",
    "http://www.ncbi.nlm.nih.gov/pubmed/24650104",
    "http://www.ncbi.nlm.nih.gov/pubmed/23213054",
    "http://www.ncbi.nlm.nih.gov/pubmed/23359227",
    "http://www.ncbi.nlm.nih.gov/pubmed/26221287",
    "http://www.ncbi.nlm.nih.gov/pubmed/23936528",
    "http://www.ncbi.nlm.nih.gov/pubmed/23395387"
  ],
  "snippets": [
    {
      "text": "Aberrant overexpression of CXCR4 is associated with worse overall survival, adenocarcinoma histology, distant metastasis, lymph node involvement in NSCLC.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26221287",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CXCR4 belongs to a family of G protein-coupled cell surface receptors and has been proved to a prognostic marker in a various tumors, including esophageal squamous cell cancer. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23822165",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The chemokine C-X-C motif receptor 4 (CXCR4) has been found to be a prognostic marker in various types of cancer, being involved in chemotaxis, stemness and drug resistance. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24650104",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The chemokine receptor CXCR4 that has been shown to be implicated in PDAC tumorigenicity and aggressiveness could serve as a prognostic marker for survival after a curative-intent surgery and was associated with the pattern of tumour recurrence (distant versus local relapse).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23650783",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "XCR4 promotes tumor growth, angiogenesis and metastasis, and is a prognostic marker in a number of different types of tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23395387",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CXCR4 has been identified as a prognostic marker for acute myeloid leukemia (AML) and other malignancies. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23213054",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The chemokine receptor CXCR4 has been found to be a prognostic marker in various types of cancer, including breast cancer. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23359227",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23936528",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "detection of CXCR4 expression will be helpful for predicting prognosis for patients with gastric cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23936528",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The chemokine receptor CXCR4 is a marker of metastatic disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22473623",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "High CXCR4 level in cancer specimens independently predicts a poor outcome for patients with node-positive breast cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22473623",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Univariate and multivariate analyses demonstrated that the high levels of nuclear CXCR4 and CXCL12 expression in hepatocytes were significantly better prognostic factors for overall and hepatic disease-free survival in patients with CLM.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22075627",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The chemokine receptor CXCR4 has been implicated in sarcoma development and has been found to be a prognostic marker for poor clinical outcome. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21234386",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "high CXCR4 expression is correlated to shorter DFS and could be used as a prognostic marker in order to stratify melanoma patients at higher progression risk.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20061818",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}